ARLINGTON, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization ...
ARLINGTON, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果